308 related articles for article (PubMed ID: 10389349)
1. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
[TBL] [Abstract][Full Text] [Related]
2. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.
Biondi B; Palmieri EA; Fazio S; Cosco C; Nocera M; Saccà L; Filetti S; Lombardi G; Perticone F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4701-5. PubMed ID: 11134131
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term thyroid hormone suppressive treatment on the cardiac functions.
Khanna CM; Dubey YS; Shankar R; Kaur G
Indian Heart J; 1997; 49(3):289-92. PubMed ID: 9291652
[TBL] [Abstract][Full Text] [Related]
4. Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma.
Hoftijzer HC; Bax JJ; Heemstra KA; Bleeker GB; Delgado V; van der Klaauw AA; Romijn JA; Smit JW; Corssmit EP
Eur J Clin Invest; 2009 Mar; 39(3):204-10. PubMed ID: 19260950
[TBL] [Abstract][Full Text] [Related]
5. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
6. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
7. Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapy.
Taillard V; Sardinoux M; Oudot C; Fesler P; Rugale C; Raingeard I; Renard E; Ribstein J; du Cailar G
Clin Endocrinol (Oxf); 2011 Nov; 75(5):709-14. PubMed ID: 21645022
[TBL] [Abstract][Full Text] [Related]
8. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.
Mercuro G; Panzuto MG; Bina A; Leo M; Cabula R; Petrini L; Pigliaru F; Mariotti S
J Clin Endocrinol Metab; 2000 Jan; 85(1):159-64. PubMed ID: 10634380
[TBL] [Abstract][Full Text] [Related]
9. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
[TBL] [Abstract][Full Text] [Related]
10. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study.
Smit JW; Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bleeker GB; Holman ER; van der Wall EE; Romijn JA; Bax JJ
J Clin Endocrinol Metab; 2005 Nov; 90(11):6041-7. PubMed ID: 16131580
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
[TBL] [Abstract][Full Text] [Related]
12. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
14. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function.
Yazici M; Gorgulu S; Sertbas Y; Erbilen E; Albayrak S; Yildiz O; Uyan C
Int J Cardiol; 2004 Jun; 95(2-3):135-43. PubMed ID: 15193811
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
16. [The analysis of exercise efficiency and autonomic function in children with nontoxic nodular goiter during suppressive L-thyroxine therapy].
Bossowski A; Gardziejczyk M; Urban M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 1998; 4(1):45-53. PubMed ID: 12818113
[TBL] [Abstract][Full Text] [Related]
17. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
Sgarbi JA; Villaça FG; Garbeline B; Villar HE; Romaldini JH
J Clin Endocrinol Metab; 2003 Apr; 88(4):1672-7. PubMed ID: 12679455
[TBL] [Abstract][Full Text] [Related]
18. Effect of L-thyroxine treatment on left ventricular function in subclinical hypothyroidism.
Franzoni F; Galetta F; Fallahi P; Tocchini L; Merico G; Braccini L; Rossi M; Carpi A; Antonelli A; Santoro G
Biomed Pharmacother; 2006 Sep; 60(8):431-6. PubMed ID: 16935462
[TBL] [Abstract][Full Text] [Related]
19. Work capacity and oxygen uptake abnormalities in hyperthyroidism.
Irace L; Pergola V; Di Salvo G; Perna B; Tedesco MA; Ricci C; Tuccillo B; Iacono A
Minerva Cardioangiol; 2006 Jun; 54(3):355-62. PubMed ID: 16733509
[TBL] [Abstract][Full Text] [Related]
20. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
